Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets May 02, 2024 Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference Mar 22, 2024 Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata Mar 05, 2024 Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results Mar 04, 2024 Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX Mar 04, 2024 Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference Feb 27, 2024 Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets Feb 26, 2024 Nektar Management To Present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA Jan 03, 2024 Nektar and Collaborators Present Preclinical Data on NKTR-255 Combined with Obinutuzumab in Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting Dec 11, 2023 Nektar Therapeutics Reports Third Quarter 2023 Financial Results Nov 07, 2023 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »